EUVIMEDEUVIMED entdecken
Übersichtsarbeit

MDSCs in Chronic Liver Disease: Updates and Future Challenges

Yi Lu, Ting Li, Liang Song, Qingling Fan, Danlin Wang, Punan Wang, Ying Han iD, Xinmin Zhou iD

Journal of Gastroenterology and Hepatology · 2025

DOI: 10.1111/jgh.17008 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Yi Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China. Hauptthemen laut MEDLINE: Liver Diseases, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Key Research and Development Program of Shaanxi, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Myeloid‐derived suppressor cells (MDSCs) are a heterogeneous population of pathologically expanded immature myeloid cells originating from bone marrow precursors, characterized by their potent immunosuppressive activity through mechanisms such as T cell inhibition, cytokine dysregulation, and metabolic interference. These cells are critically implicated in diverse pathological contexts, including cancer progression, chronic infections, and inflammatory disorders. In chronic liver diseases, MDSCs contribute to the pathogenesis of multiple conditions, such as chronic viral hepatitis, alcoholic liver disease (ALD), nonalcoholic fatty liver disease (NAFLD), and autoimmune liver diseases (AILD). Emerging evidence highlights their dual roles in both exacerbating tissue injury and modulating immune responses, positioning MDSCs as pivotal regulators of disease progression and potential therapeutic targets. In this review, we summarize the biological roles of MDSCs in a variety of chronic inflammatory liver diseases and explore the therapeutic potential of targeting these diseases to provide new insight for the treatment of chronic liver diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver DiseasesMyeloid-Derived Suppressor CellsHumansChronic DiseaseLiver Diseases, AlcoholicNon-alcoholic Fatty Liver DiseaseAnimalsDisease ProgressionHepatitis, Viral, Human

Stichwörter der Autor:innen

T cellsautoimmune liver diseasemyeloid‐derived suppressor cellstreatmentviral hepatitis

Autor:innen und Institutionen

  • Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China.
  • Department of Digestive Diseases, Xijing Hospital of Air Force Military Medical University, Xi'an, Shaanxi, China.

ORCID-Profile: Ying Han, Xinmin Zhou

Förderung

  • Key Research and Development Program of Shaanxi
  • National Natural Science Foundation of China

Zitieren

APA

Lu, Y., Li, T., Song, L., Fan, Q., Wang, D., Wang, P., Han, Y., & Zhou, X. (2025). MDSCs in Chronic Liver Disease: Updates and Future Challenges. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.17008

Vancouver

Lu Y, Li T, Song L, Fan Q, Wang D, Wang P, et al. MDSCs in Chronic Liver Disease: Updates and Future Challenges. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.17008

BibTeX
@article{Lu2025,
  author = {Lu, Yi and Li, Ting and Song, Liang and Fan, Qingling and Wang, Danlin and Wang, Punan and Han, Ying and Zhou, Xinmin},
  title = {MDSCs in Chronic Liver Disease: Updates and Future Challenges},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2025},
  doi = {10.1111/jgh.17008}
}
Kostenlos starten →